The network becomes national!
From January 1st 2019 the network expands from being a regional to a national network.
From January 1st 2019 the network expands from being a regional to a national network.
Interesting research results, new possibilities for cooperation and a surprising wildlife are the keywords from this year's network meeting.
Members of the network, sign up for this year's network meeting!
A paper exploring the clinical value of tamoxifen metabolites in serum was published in Breast Cancer Research in November 2017.
Professor and group leader in the network, Vessela Kristensen, is awarded the "Kong Olav Vs Kreftforskningspris" for her work with breast cancer research.
Several network members are part of the group publishing a paper in OncoImmunology last year on the inverse relationship between estrogen and immune cells in breast cancer.
The Norwegian Cancer Society supports research projects with funding every autumn, and one of the groups receiving funding in November 2017 is led by network member Gunhild Mælandsmo.
In the recently published article in Nature Communications we found that DNA methylation at enhancers and transcription factor binding regions is a key feature distinguishing and explaining estrogen receptor positive breast cancer.
Can the number of blood vessels in tumor tissue be used as a prognostic marker?
Members of the network and OSBREAC have participated in a major study published October 23 in Nature and Nature Genetics.
